Meetings - The ASCO Post

/ Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC

Case 3: Metastatic RCC With Symptomatic Progression After IO/IO

This is Part 3 of Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, ...

/ Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC

Case 2: Advanced RCC With Mild Disease Progression After IO/IO

This is Part 2 of Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video,...

/ Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC

Case 1: RCC With Disease Progression After Adjuvant Pembrolizumab

This is Part 1 of Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, ...

Optimizing Patient Selection and Outcomes in Post-IO Advanced RCC

Case 3: Metastatic RCC With Symptomatic Progression After IO/IO

Case 2: Advanced RCC With Mild Disease Progression After IO/IO

Case 1: RCC With Disease Progression After Adjuvant Pembrolizumab

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

American Cancer Society Announces New Pediatric Adolescent and Young Adult Cancer Journal

Colorectal Cancer Duloxetine Not Effective in Preventing Oxaliplatin-Induced Peripheral Neuropathy

Advanced Prostate Cancer Radiographic Progression and PSA Increase in Patients Treated With Enzalutamide

CLL Linked to Increased Skin Cancer Risk and Mortality